Oleuropein and Cancer Chemoprevention: The Link is Hot

Ammad Ahmad Farooqi1, Sundas Fayyaz2, Ana Sanches Silva3,4

  • 1Laboratory for Translational Oncology and Personalized Medicine, Rashid Latif Medical College, Lahore 54000, Pakistan. ammadfarooqi@rlmclahore.com.

Insights

Oleuropein, a natural compound, shows significant anticancer and cancer-suppressing effects by modulating oncogenic pathways. Further research into this phenolic compound offers promising therapeutic and chemopreventive perspectives for cancer treatment.

Area of Science:

  • Oncology
  • Natural Product Chemistry
  • Molecular Biology

Background:

  • Cancer is a complex disease driven by altered cellular pathways leading to uncontrolled growth.
  • Natural compounds offer a promising avenue for chemoprevention and cancer treatment due to their potential for low toxicity and economic viability.
  • Oleuropein, a phenolic compound from sources like olive oil, is known to influence various oncogenic signaling pathways.

Purpose of the Study:

  • To review and critically analyze the existing literature on the anticancer and onco-suppressive activities of oleuropein.
  • To elucidate the molecular mechanisms underlying oleuropein's anticarcinogenic and therapeutic effects.
  • To discuss the limitations and future research perspectives for oleuropein in cancer therapy.

Main Methods:

  • Comprehensive literature search and review of scientific databases.
  • Critical analysis of studies investigating oleuropein's effects on cancer cells and signaling pathways.
  • Synthesis of current knowledge on molecular mechanisms and therapeutic potential.

Main Results:

  • Oleuropein demonstrates significant anticancer and onco-suppressive activities.
  • Evidence suggests oleuropein modulates key oncogenic signaling pathways involved in cancer development and progression.
  • The compound exhibits potential as both a chemopreventive agent and a therapeutic option.

Conclusions:

  • Oleuropein possesses notable anticancer properties, supported by its ability to modulate critical oncogenic pathways.
  • The review highlights the therapeutic potential of oleuropein, warranting further investigation into its mechanisms and clinical applications.
  • Despite limitations, oleuropein presents promising perspectives for future cancer research and treatment strategies.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.9K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.6K